Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jul 30, 2025 | (FY)Jul 30, 2024 | (FY)Jul 30, 2023 | (FY)Jul 30, 2022 | (FY)Jul 30, 2021 | (FY)Jul 30, 2020 | (FY)Jul 30, 2019 | (FY)Jul 30, 2018 | (FY)Jul 30, 2017 | (FY)Jul 30, 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (direct method) | ||||||||||
| Cash income from operating activities | -6.93%1.79B | -37.35%1.92B | 36.88%3.07B | 114.83%2.24B | -13.24%1.04B | -10.52%1.2B | 23.19%1.34B | 19.21%1.09B | 90.56%914.63M | 0.85%479.98M |
| Revenue from customers | -6.95%1.79B | -38.10%1.92B | 38.43%3.1B | 114.83%2.24B | -13.24%1.04B | -13.59%1.2B | 27.57%1.39B | 19.21%1.09B | 71.90%914.63M | 11.80%532.08M |
| Other cash income from operating activities | 15.53%2.02M | 105.06%1.75M | ---34.52M | ---- | ---1K | ---- | ---47.73M | ---- | ---- | ---52.1M |
| Cash paid | -15.64%-1.11B | 6.06%-958.97M | 3.08%-1.02B | -40.36%-1.05B | 17.00%-750.44M | -2.61%-904.12M | -34.23%-881.14M | -9.11%-656.44M | -27.76%-601.62M | -23.75%-470.9M |
| Payments to suppliers for goods and services | -15.64%-1.11B | 6.06%-958.97M | 3.08%-1.02B | -40.36%-1.05B | 17.00%-750.44M | -2.61%-904.12M | -34.23%-881.14M | -9.11%-656.44M | -27.76%-601.62M | -23.75%-470.9M |
| Direct dividend received | 185.81%20.79M | --7.28M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Direct interest paid | ---4.94M | ---- | ---- | -8.67%-16.98M | 0.99%-15.62M | -46.45%-15.78M | -10,565.35%-10.77M | 88.82%-101K | -262.65%-903K | ---249K |
| Direct interest received | ---- | -37.95%11.5M | --18.54M | ---- | ---- | ---- | --5.49M | ---- | ---- | ---- |
| Direct tax refund paid | 70.33%-124.35M | 22.30%-419.12M | -1,621.99%-539.43M | -262.17%-31.33M | 172.66%19.32M | 83.69%-26.59M | -932.87%-162.98M | 42.77%-15.78M | -1,210.36%-27.57M | 69.63%-2.1M |
| Operating cash flow | 1.57%570.8M | -63.14%561.96M | 33.91%1.52B | 284.59%1.14B | 15.90%296.07M | -13.05%255.46M | -29.71%293.78M | 46.90%417.98M | 4,129.06%284.53M | -92.39%6.73M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0.63%-505.35M | -417.36%-508.54M | 55.83%-98.29M | -420.40%-222.52M | 60.69%-42.76M | 84.95%-108.78M | -151.79%-722.97M | -263.00%-287.14M | -163.28%-79.1M | 380.17%125.01M |
| Capital expenditure reported | -54.93%-15.03M | 17.06%-9.7M | 6.21%-11.69M | -15.31%-12.47M | 16.17%-10.81M | 39.40%-12.9M | 17.29%-21.29M | -106.03%-25.74M | 29.72%-12.49M | 66.60%-17.77M |
| Net PPE purchase and sale | -1.79%-266.52M | -57.17%-261.84M | -328.62%-166.6M | -43.29%-38.87M | 71.66%-27.13M | -25.31%-95.72M | -26.10%-76.39M | 10.76%-60.58M | -3.73%-67.88M | -5.36%-65.44M |
| Net intangibles purchas and sale | 8.83%-475K | ---521K | ---- | ---- | ---- | -314.81%-224K | 95.63%-54K | 32.44%-1.24M | -4,718.42%-1.83M | 61.22%-38K |
| Net business purchase and sale | 55.07%-36.2M | ---80.56M | ---- | --21.63M | ---- | ---- | ---831.26M | ---- | 99.91%-800K | ---849.53M |
| Net investment purchase and sale | -20.02%-187.13M | -294.89%-155.91M | 141.13%80M | ---194.48M | ---- | ---- | 200.21%205.43M | -176,824.14%-205M | -99.99%116K | 3,085.08%1.03B |
| Dividends received (cash flow from investment activities) | ---- | ---- | ---- | ---- | ---- | ---- | 0.00%2K | 0.00%2K | --2K | ---- |
| Interest received (cash flow from investment activities) | ---- | ---- | ---- | ---- | ---- | ---- | -88.02%648K | 163.80%5.41M | -91.92%2.05M | -33.93%25.36M |
| Net other investing changes | ---- | ---- | ---- | 134.66%1.67M | -7,632.81%-4.82M | 208.47%64K | -2,066.67%-59K | -99.83%3K | 19,144.44%1.73M | --9K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 0.63%-505.35M | -417.36%-508.54M | 55.83%-98.29M | -420.40%-222.52M | 60.69%-42.76M | 84.95%-108.78M | -151.79%-722.97M | -263.00%-287.14M | -163.28%-79.1M | 380.17%125.01M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -156.36%-372.75M | 89.68%-145.4M | -124.30%-1.41B | -737.52%-628.13M | 172.68%98.53M | -164.02%-135.57M | 307.41%211.75M | -95.82%-102.09M | 22.73%-52.14M | 14.54%-67.47M |
| Net issuance payments of debt | ---- | --291.14M | ---- | -312.76%-310M | --145.7M | --0 | --360M | ---- | ---- | ---- |
| Net common stock issuance | -103.43%-9.09M | 147.34%264.98M | ---559.77M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash dividends paid | 12.77%-346.59M | 52.65%-397.31M | -172.47%-839.12M | -824.90%-307.97M | 73.31%-33.3M | 6.20%-124.76M | -33.35%-133M | -100.02%-99.74M | 25.00%-49.86M | 15.78%-66.48M |
| Net other financing activities | 65.17%-17.07M | -145.30%-49M | 1.70%-19.98M | 26.77%-20.32M | -28.30%-27.75M | -22.29%-21.63M | -275.38%-17.69M | -3.70%-4.71M | -130.66%-4.54M | ---1.97M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -156.36%-372.75M | 89.68%-145.4M | -124.30%-1.41B | -737.52%-628.13M | 172.68%98.53M | -164.02%-135.57M | 307.41%211.75M | -95.82%-102.09M | 22.73%-52.14M | 14.54%-67.47M |
| Net cash flow | ||||||||||
| Beginning cash position | -12.58%638.76M | 2.09%730.65M | 68.54%715.71M | 503.41%424.66M | 19.63%70.38M | -78.61%58.83M | 16.08%274.98M | 159.85%236.89M | 267.75%91.16M | -56.52%24.79M |
| Current changes in cash | -234.11%-307.29M | -622.13%-91.97M | -93.88%17.62M | -18.15%287.98M | 3,067.10%351.83M | 105.11%11.11M | -856.36%-217.43M | -81.25%28.75M | 138.53%153.29M | 283.06%64.27M |
| Effect of exchange rate changes | 381.01%380K | 102.95%79K | -187.11%-2.68M | 25.19%3.07M | 456.24%2.45M | -65.65%441K | -86.26%1.28M | 223.41%9.34M | -459.33%-7.57M | -26.87%2.11M |
| End cash Position | -48.05%331.85M | -12.58%638.76M | 2.09%730.65M | 68.54%715.71M | 503.41%424.66M | 19.63%70.38M | -78.61%58.83M | 16.08%274.98M | 159.85%236.89M | 267.75%91.16M |
| Free cash from | -10.37%259.61M | -78.35%289.66M | 26.11%1.34B | 350.64%1.06B | 65.67%235.4M | -27.32%142.09M | -40.41%195.5M | 64.23%328.07M | 358.28%199.76M | -183.30%-77.34M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |